NewcelX Ltd.

NewcelX Ltd.
NewcelX is a biopharmaceutical company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, including Type 1 Diabetes and ALS.
About
What does NewcelX Ltd. do?
NewcelX is an innovative biopharmaceutical company focused on developing transformative stem-cell-derived therapies for Type 1 Diabetes and other serious diseases. The company leverages a human pluripotent stem cell (hPSC) technology platform for scalable cell expansion and precise differentiation, with its lead program, NCEL-101 (IsletRx), designed to restore functional insulin production. Additionally, NewcelX is developing treatments for neurodegenerative diseases like ALS with its AstroRx® a…
Is NewcelX Ltd. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for NewcelX Ltd. is 74 out of 100, based on site security posture and privacy practices.
What is NewcelX Ltd.'s revenue?
StartupHub estimates NewcelX Ltd.'s annual revenue at $2.3M (range $1.5M to $3.4M, 63% confidence), based on comparable companies in the sector.
Where is NewcelX Ltd. headquartered?
NewcelX Ltd. is headquartered in Zurich, Switzerland.
When was NewcelX Ltd. founded?
NewcelX Ltd. was founded in 2025.
What industry does NewcelX Ltd. operate in?
NewcelX Ltd. operates in Biotech, MedTech, Cellular Agriculture, Drug Discovery, Clinical Trials, Genomics.
How many employees does NewcelX Ltd. have?
NewcelX Ltd. has approximately 30 people on record.
AI precision medicine company transforming cancer diagnostics and patient outcomes through cutting-edge foundation models and multi-modal data.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 5 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.


